HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ting Wei Selected Research

N-Acetylglucosaminyltransferases

8/2012The role of N-acetylglucosaminyltransferases V in the malignancy of human hepatocellular carcinoma.
10/2011Down-regulation of GnT-V inhibits nasopharyngeal carcinoma cell CNE-2 malignancy in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ting Wei Research Topics

Disease

46Neoplasms (Cancer)
05/2022 - 05/2008
10Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2022 - 11/2015
8Infections
01/2020 - 03/2003
7Prostatic Neoplasms (Prostate Cancer)
01/2021 - 06/2010
5Hemangioma (Angioma)
11/2021 - 04/2005
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2019
4Breast Neoplasms (Breast Cancer)
01/2021 - 12/2019
4Hepatocellular Carcinoma (Hepatoma)
01/2020 - 08/2012
3Inflammation (Inflammations)
01/2022 - 04/2013
3Hypersensitivity (Allergy)
11/2021 - 05/2005
3Neurodegenerative Diseases (Neurodegenerative Disease)
02/2021 - 04/2013
3Adenocarcinoma of Lung
01/2021 - 01/2020
3Lung Neoplasms (Lung Cancer)
01/2021 - 01/2020
3Carcinogenesis
03/2020 - 11/2016
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 01/2021
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2021 - 03/2021
2Arteriovenous Malformations (Arteriovenous Malformation)
12/2019 - 04/2016
2Hemolysis
05/2019 - 05/2018
2Nasopharyngeal Carcinoma
08/2017 - 10/2011
2Reperfusion Injury
02/2015 - 01/2014
2Glaucoma
02/2015 - 01/2014
2Non-alcoholic Fatty Liver Disease
09/2014 - 10/2012
1Carcinoma (Carcinomatosis)
05/2022
1Foreign-Body Reaction
01/2022
1Foreign Bodies (Foreign Body)
01/2022
1Necrosis
01/2022
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2022
1Bites and Stings (Sting)
11/2021
1Nausea
11/2021
1Pain (Aches)
11/2021
1COVID-19
08/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2021
1Neuroinflammatory Diseases
02/2021
1Cardiomyopathies (Cardiomyopathy)
01/2021
1Renal Cell Carcinoma (Grawitz Tumor)
01/2021

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
06/2022 - 03/2004
9Immune Checkpoint InhibitorsIBA
05/2022 - 01/2019
8Pharmaceutical PreparationsIBA
04/2021 - 01/2016
6Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2020
4LipidsIBA
11/2021 - 04/2013
4MicroRNAs (MicroRNA)IBA
02/2021 - 01/2017
4Cisplatin (Platino)FDA LinkGeneric
01/2021 - 01/2019
4PolymersIBA
05/2019 - 01/2016
4alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA
08/2017 - 06/2010
3PlatinumIBA
01/2022 - 01/2019
3Fatty Acids (Saturated Fatty Acids)IBA
11/2021 - 10/2012
3LipopolysaccharidesIBA
02/2021 - 04/2013
3RNA (Ribonucleic Acid)IBA
01/2021 - 01/2020
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 07/2019
3Propranolol (Inderal)FDA LinkGeneric
01/2021 - 01/2017
3Histones (Histone)IBA
01/2021 - 01/2021
3AntigensIBA
04/2008 - 03/2004
2Long Noncoding RNAIBA
02/2021 - 01/2017
2Docetaxel (Taxotere)FDA Link
01/2021 - 05/2015
2AndrogensIBA
01/2021 - 01/2021
2Small Interfering RNA (siRNA)IBA
12/2019 - 06/2010
2Biocompatible Materials (Biomaterials)IBA
05/2019 - 07/2018
2Peptides (Polypeptides)IBA
05/2019 - 05/2018
2EnzymesIBA
08/2017 - 04/2008
2Biological ProductsIBA
01/2017 - 05/2008
2RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2017 - 11/2016
2Liposomes (Liposome)IBA
11/2016 - 05/2015
2Retinaldehyde (Retinal)IBA
02/2015 - 01/2014
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2013 - 06/2012
2N-AcetylglucosaminyltransferasesIBA
08/2012 - 10/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2008 - 04/2005
2Recombinant ProteinsIBA
04/2008 - 03/2004
1Chemokine ReceptorsIBA
05/2022
1Capsules (Microcapsules)IBA
01/2022
1Histocompatibility Antigens Class IIBA
01/2022
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022
1Histocompatibility Antigens Class IIIBA
01/2022
1Phosphorylcholine (Phosphocholine)IBA
01/2022
1Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
01/2022
1GelatinIBA
01/2022
1MethacrylatesIBA
01/2022
1sulfobetaineIBA
01/2022
1Estrogens (Estrogen)FDA Link
11/2021
1Progesterone Receptors (Progesterone Receptor)IBA
11/2021
1Gonadal Steroid Hormones (Sex Hormones)IBA
11/2021
1WastewaterIBA
08/2021
1Agammaglobulinaemia Tyrosine KinaseIBA
04/2021
1Deubiquitinating Enzyme CYLDIBA
04/2021
1Monoclonal AntibodiesIBA
04/2021
1Rituximab (Mabthera)FDA Link
04/2021
1Vincristine (Oncovin)FDA LinkGeneric
03/2021
1NEO2734IBA
01/2021
1Whey ProteinsIBA
01/2021
1Tachypleus tridentatus tachyplesin peptideIBA
01/2021

Therapy/Procedure

19Therapeutics
05/2022 - 04/2005
9Drug Therapy (Chemotherapy)
06/2022 - 06/2009
9Immunotherapy
01/2022 - 01/2019
2Castration
01/2021 - 07/2019
2Radiotherapy
08/2017 - 08/2014
1Islets of Langerhans Transplantation
01/2022
1Glycemic Control
01/2022
1Lab-On-A-Chip Devices
01/2022
1Immunomodulation
01/2022
1VAP-cyclo protocol
03/2021